Skip to main content
SpringerLink
Log in

Spectrum of p53 mutations in low-grade B-cell malignancies

  • Letter to the Editor
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Preudhomme C, Fenaux P . The clinical significance of mutations of the p53 tumour suppressor gene in haematological malignancies. Br J Haematol 1997; 98: 502–511.

    Article  CAS  PubMed  Google Scholar 

  2. Bromidge TJ, Howe DJ . Screening of the entire coding region of p53 in low grade lymphoproliferative disorders. J Clin Pathol (Mol Pathol) 2000; 53: 216–218.

    Article  CAS  Google Scholar 

  3. Howe DJ, Bromidge TJ, Stack-Dunne M, Davies SV, Paxton A, Phillips MJ et al. Trisomy 12 is a rare event in cases of CLL with typical immunophenotype and morphology. Hematology 1997; 2: 373–378.

    Article  CAS  PubMed  Google Scholar 

  4. Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibbotson RE et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177–1184.

    CAS  PubMed  Google Scholar 

  5. Bromidge T, Lowe C, Prentice A, Johnson S . p53 intronic point mutation, aberrant splicing and telomeric associations in a case of B-chronic lymphocytic leukaemia. Br J Haematol 2000; 111: 223–229.

    Article  CAS  PubMed  Google Scholar 

  6. Cordone I, Masi S, Romana Mauro F, Soddu S, Morsilli O, Valentini T et al. p53 expression in B-cell chronic lymphocytic leukaemia: a marker of disease progression and poor prognosis. Blood 1998; 91: 4342–4349.

    CAS  PubMed  Google Scholar 

  7. Trbusek M, Malcikova J, Smardova J, Kuhrova V, Mentzlova D, Francova H et al. Inactivation of p53 and deletion of ATM in B-CLL patients in relation in IgVH mutation status and previous treatment. Leukemia 2006; 20: 1159–1161.

    Article  CAS  PubMed  Google Scholar 

  8. Soussi T, Rubio-Nevado JM, Hamroun D, Beroud C . The p53 Mutation Handbook. Available online http://p53.free.fr. Last accessed 25/07/07.

  9. Secchiero P, Barbarotto E, Tiribelli M, Zerbinati C, Grazia di Iasio M, Gonelli A et al. Functional integrity of the p53-mediated apoptotic pathway induced by the nongenotoxic agent nutlin-3 in B-cell chronic lymphocytic leukemia (B-CLL). Blood 2006; 107: 4122–4129.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by The Musgrove Leukaemic Group Somerset.

Author information

Authors and Affiliations

  1. Leukaemia Research Unit, Taunton and Somerset NHS Trust, Musgrove Park Hospital, Taunton, Somerset, UK

    T Bromidge & D Howe

  2. Department of Haematology, Taunton and Somerset NHS Trust, Musgrove Park Hospital, Taunton, Somerset, UK

    S Johnson

Authors
  1. T Bromidge
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. D Howe
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to T Bromidge.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bromidge, T., Johnson, S. & Howe, D. Spectrum of p53 mutations in low-grade B-cell malignancies. Leukemia 22, 1071–1073 (2008). https://doi.org/10.1038/sj.leu.2405002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2405002

  • Springer Nature Limited

This article is cited by

Search

Navigation